Director/ PDMR Shareholding

RNS Number : 5603U
Judges Scientific PLC
07 April 2016
 

Press Release

7 April 2016

 

Judges Scientific plc

 

("Judges Scientific", "Judges", the "Company" or the "Group")

 

Director/PDMR Shareholding

 

Judges Scientific, a group involved in the buy and build of scientific instrument businesses, has today been advised that purchases of ordinary shares of 5p each in the Company ("Ordinary Shares") were made on 5 April 2016 by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

 

A total of nine Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company.  His resulting interest in the Company is 916,709 Ordinary shares representing 15.02 per cent of the issued Ordinary Share capital.  In addition, he holds options over 9,275 Ordinary Shares under the Company's Share Option Plans.

 

A total of 134 Ordinary shares were purchased on behalf of Brad Ormsby, the Group Finance Director of the Company.  His resulting interest in the Company is 134 Ordinary Shares representing nil per cent of the issued Ordinary Share capital.  In addition, he holds options over 60,000 Ordinary Shares under the Company's Share Option Plans.

 

The purchases by the Trustees were made at a price of 1781.1p per Ordinary Share.  Purchases of a further 701 Ordinary Shares were made on the same date and at the same price on behalf of 78 other members of staff under the Company's Share Incentive Plan.

 

For further information please contact:

 

Judges Scientific

 

 

David Cicurel, CEO

Tel: +44 (0) 203 829 6970

 

Brad Ormsby, Group FD

 

 

 

Shore Capital (Nominated Adviser & Broker)

 

Stephane Auton

Edward Mansfield

 

Tel: +44 (0) 20 7408 4090

Media enquiries:

Abchurch (Financial Public Relations)

 

Philip Dennis

Quincy Allan

Nessyah Hart

Tel: +44 (0) 20 7398 7702

www.abchurch-group.com

 

 

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group involved in the buy and build of scientific instrument businesses.  The Group currently consists of 14 businesses acquired since it was first admitted to AIM in 2003.

 

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, the scientific communities, manufacturers and regulatory authorities.  The UK is a recognised centre of excellence for scientific instruments. The Group holds 5 Queens' awards for innovation and export.

 

Judges Scientific maintains a policy to selectively acquire businesses that generate sustainable profits and cash. Shareholder returns are created through the repayment of debt, organic growth and dividends.

 

The Group's companies predominantly operate in niche end markets, with long term growth fundamentals and resilient margins.

 

For further information, please visit www.judges.uk.com

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHGMGGDVNZGVZM
UK 100

Latest directors dealings